Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (TNF) antibody

Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (TNF) antibody

US Patent 12122825 · Granted Oct 22, 2024

Estimated economic value: $462,849,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
Manufacturing methods for producing anti-TNF antibody compositions2024
RNA polymerase variants for co-transcriptional capping2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024
Anti-tumor necrosis factor (TNF) antibodies and compositions thereof2024